Analyst Michael Matson from Needham reiterated a Buy rating on Hologic (HOLX – Research Report) and keeping the price target at $90.00.

Hologic (HOLX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant ...

According to the reproductive desire of the patient and the severity of symptoms surgical procedures comprise myomectomy, endometrial ablation or hysterectomy. In 2009 the Bayer Healthcare ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...

The Epione platform enhances the accuracy of tumour ablation procedures by supporting physicians in planning optimal ...

NeuroOne will get $3 million upfront for an exclusive license to distribute its radiofrequency ablation system designed to treat neurological disorders such as epilepsy and Parkinson's disease.

The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...

Nanoparticle-directed therapy has shown significant promise for treating localised prostate cancer, achieving tumour ablation ...

More than six million Americans experience atrial fibrillation, or Afib, each year. Penn Stare Health Heart and Vascular is now offering a new, very focused and safe approach to treating Afib, ...

The US Food and Drug Administration has approved a third pulsed-field ablation system, one that can also deliver radiofrequency energy, for the treatment of atrial fibrillation (AF), device maker ...